Our newest Featured Column reprints one of the most widely talked-about legal blog posts of recent weeks, which originally appeared at James Beck and Mark Herrmann's Drug & Device Law Blog. Beck & Herrmann assess how well the courts have done over the past 25 years in screening out ill-founded litigation in their field of practice (pharmaceuticals and medical devices). The grades they award in such areas as scientific evidence, preemption, class action practice and discovery aren't always what might be expected.